TONIX PHARMACEUTICALS HOLDING CORP. Cash, Period Increase (Decrease)
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Cash, Period Increase (Decrease) of $20.00 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2015-05-08
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for the quarter ending 2015-03-31 was $20.00M, a 51.63% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for the quarter ending 2014-12-31 was -$8.04M, a 1128.52% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for the quarter ending 2014-09-30 was $2.36M, a 67.94% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for the quarter ending 2014-06-30 was -$5.68M.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for fiscal 2014 was $29.98M, a 367.23% increase from fiscal 2013.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for fiscal 2013 was $6.42M, a 267.95% increase from fiscal 2012.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for fiscal 2012 was $1.74M.
- TONIX PHARMACEUTICALS HOLDING CORP. cash, period increase (decrease) for fiscal 2011 was -$24.24K, a 137.70% decline from fiscal 2010.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 3 month as first filed | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 6 month as first filed | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 9 month as first filed | Cash, Period Increase (Decrease) 12 month | Cash, Period Increase (Decrease) 12 month as first filed | Cash, Period Increase (Decrease) 43 month | Cash, Period Increase (Decrease) 46 month | Cash, Period Increase (Decrease) 55 month | Cash, Period Increase (Decrease) 58 month | Cash, Period Increase (Decrease) 61 month | Cash, Period Increase (Decrease) 64 month | Cash, Period Increase (Decrease) 67 month | Cash, Period Increase (Decrease) 70 month | Cash, Period Increase (Decrease) 73 month | Cash, Period Increase (Decrease) 76 month | Cash, Period Increase (Decrease) 79 month | Cash, Period Increase (Decrease) 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $20.00M 10-Q · filed 2015-05-08 | $11.95M derived: sum of 2 quarters · filed 2015-05-08 | $14.31M derived: sum of 3 quarters · filed 2015-05-08 | $8.63M derived: sum of 4 quarters · filed 2015-05-08 | ||||||||||||||||
| 2014-12-31 | -$8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$5.69M derived: sum of 2 quarters · filed 2015-02-27 | -$11.36M derived: sum of 3 quarters · filed 2015-02-27 | $29.98M 10-K · filed 2015-02-27 | ||||||||||||||||
| 2014-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$3.32M derived: sum of 2 quarters · filed 2014-11-07 | $38.02M 10-Q · filed 2014-11-07 | $38.81M derived: sum of 4 quarters · filed 2015-05-08 | ||||||||||||||||
| 2014-06-30 | -$5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $35.67M 10-Q · filed 2014-08-08 | $36.45M derived: sum of 3 quarters · filed 2015-05-08 | $43.80M derived: sum of 4 quarters · filed 2015-05-08 | ||||||||||||||||
| 2014-03-31 | $41.34M 10-Q · filed 2015-05-08 | $42.13M derived: sum of 2 quarters · filed 2015-05-08 | $49.48M derived: sum of 3 quarters · filed 2015-05-08 | $49.12M derived: sum of 4 quarters · filed 2015-05-08 | $49.55M 10-Q · filed 2014-05-13 | |||||||||||||||
| 2013-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.13M derived: sum of 2 quarters · filed 2015-02-27 | $7.78M derived: sum of 3 quarters · filed 2015-02-27 | $6.42M 10-K · filed 2015-02-27 | $8.20M 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $7.00M derived: sum of 2 quarters · filed 2014-11-07 | $5.63M 10-Q · filed 2014-11-07 | $5.63M 10-Q · filed 2013-11-13 | $7.38M derived: sum of 4 quarters · filed 2014-11-07 | $7.42M 10-Q · filed 2013-11-13 | ||||||||||||||
| 2013-06-30 | -$355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$1.72M 10-Q · filed 2014-08-08 | -$1.72M 10-Q · filed 2013-08-14 | $32.47K derived: sum of 3 quarters · filed 2014-08-08 | -$1.27M derived: sum of 4 quarters · filed 2014-08-08 | $68.04K 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | -$1.36M 10-Q · filed 2014-05-13 | -$1.36M 10-Q · filed 2013-05-07 | $387.47K derived: sum of 2 quarters · filed 2014-05-13 | -$914.61K derived: sum of 3 quarters · filed 2014-05-13 | -$2.08M derived: sum of 4 quarters · filed 2014-05-13 | $423.74K 10-Q · filed 2013-05-07 | ||||||||||||||
| 2012-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $447.39K derived: sum of 2 quarters · filed 2014-03-28 | -$716.26K derived: sum of 3 quarters · filed 2014-03-28 | $1.74M 10-K · filed 2014-03-28 | $1.74M 10-K · filed 2013-03-11 | $1.79M 10-K/A · filed 2013-11-22 | ||||||||||||||
| 2012-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$2.47M derived: sum of 2 quarters · filed 2013-11-13 | -$5.47K 10-Q · filed 2013-11-13 | $28.82K derived: sum of 4 quarters · filed 2013-11-22 | $35.65K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.30M 10-Q · filed 2013-08-14 | $1.33M derived: sum of 3 quarters · filed 2013-11-22 | $1.32M derived: sum of 4 quarters · filed 2013-11-22 | $1.34M 10-Q · filed 2012-08-13 | |||||||||||||||
| 2012-03-31 | $2.46M 10-Q · filed 2013-05-07 | $2.49M derived: sum of 2 quarters · filed 2013-11-22 | $2.48M derived: sum of 3 quarters · filed 2013-11-22 | $2.50M derived: sum of 4 quarters · filed 2013-11-22 | $2.50M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $34.29K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $19.78K derived: sum of 2 quarters · filed 2013-11-22 | $38.76K derived: sum of 3 quarters · filed 2013-11-22 | -$24.24K 10-K/A · filed 2013-11-22 | $41.12K 10-K · filed 2012-03-30 | |||||||||||||||
| 2011-09-30 | -$14.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $4.47K derived: sum of 2 quarters · filed 2012-11-14 | -$58.53K 10-Q · filed 2012-11-14 | -$4.42K 10-Q · filed 2011-10-07 | $14.29K derived: sum of 4 quarters · filed 2012-11-14 | $205.00 10-Q · filed 2011-10-07 | ||||||||||||||
| 2011-06-30 | $18.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$44.02K 10-Q · filed 2012-08-13 | -$3.88K 10-Q · filed 2011-08-15 | $28.80K derived: sum of 3 quarters · filed 2012-08-13 | $28.76K derived: sum of 4 quarters · filed 2012-08-13 | $747.00 10-Q · filed 2011-08-15 | ||||||||||||||
| 2011-03-31 | -$62.99K 10-Q · filed 2012-05-15 | $9.83K derived: sum of 2 quarters · filed 2012-05-15 | $9.78K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | $72.82K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $72.78K derived: sum of 2 quarters · filed 2012-03-30 | $64.29K 10-K · filed 2012-03-30 | |||||||||||||||||
| 2010-09-30 | -$45.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-07 | -$8.53K 10-Q · filed 2011-10-07 | ||||||||||||||||||
| 2010-06-30 | -$8.48K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |